Pharma Partnership Stock Tracking

This page is under construction. It is intended to track all pharmaceutical partnership related activities starting on July 7. 

***7/11 BDSI licensing agreement with Purdue Pharma

BioDelivery Sciences (BDSI) Enters Agreement With Purdue Pharma (Canada) For Licensing And Distribution Rights Of BELBUCA

https://www.streetinsider.com/dr/news.php?id=13091141&gfv=1
***7/11 ABZA licensing agreement with OBI

Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement

http://www.pipelinereview.com/index.php/2017071165198/More-News/Abzena-and-OBI-Pharma-Sign-ThioBridge-Licence-Agreement.html
***7/11 cytovia (IMNP oncology subsidiary) licensing agreement with Pint Pharma

Immune Pharma (IMNP) Subsidiary Enters into Definitive Agreement with Pint Pharma for Licensing and Commercialization of Ceplene in Latin America

https://www.streetinsider.com/dr/news.php?id=13088978&gfv=1
*** 7/10 CAPR DMD focused clinical stage company has ended partnership with JnJ/Janssen

J&J did not exercise option on Capricor Stem Cell Partnership

http://pipelinereview.com/index.php/2017070765181/DNA-RNA-and-Cells/Capricor-Therapeutics-Retains-Full-Rights-to-CAP-1002-as-Janssen-Biotech-Inc.-Decides-Not-to-Exercise-Option.html
* ** 7/10 OPHT: Licensing agreement halt

Novartis hits pause on Fovista agreement

Due to lack of effectiveness shown so far for treatment of anti PDGF in wet amd. 

http://www.biopharmadive.com/news/novartis-ophthotech-fovista-licensing-letter-agreement/446712/

***Zealand Pharma: Helsinn Healthcare 7/6/2017

License Agreement Between Zealand Pharma a/S and Helsinn Healthcare Sa

***CNAT: Novartis : 7/7/2017

Conatus Pharma Announces Effectiveness Of Exclusive License For Global Development And Commercialization Of Emricasan With Receipt Of $7 Million Payment